Literature DB >> 29193409

More insights into the pharmacological effects of artemisinin.

Abdelmajid Zyad1, Mounir Tilaoui1, Abdeslam Jaafari1, Moulay Ali Oukerrou1, Hassan Ait Mouse1.   

Abstract

Artemisinin is one of the most widely prescribed drugs against malaria and has recently received increased attention because of its other potential biological effects. The aim of this review is to summarize recent discoveries of the pharmaceutical effects of artemisinin in basic science along with its mechanistic action, as well as the intriguing results of recent clinical studies, with a focus on its antitumor activity. Scientific evidence indicates that artemisinin exerts its biological activity by generating reactive oxygen species that damage the DNA, mitochondrial depolarization, and cell death. In the present article review, scientific evidence suggests that artemisinin is a potential therapeutic agent for various diseases. Thus, this review is expected to encourage interested scientists to conduct further preclinical and clinical studies to evaluate these biological activities.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  antitumor activity; artemisinin; pharmacological activities

Mesh:

Substances:

Year:  2017        PMID: 29193409     DOI: 10.1002/ptr.5958

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  9 in total

1.  Pharmacy Leadership Amid the Pandemic: Maintaining Patient Safety During Uncertain Times.

Authors:  Irene Derrong Lin; John B Hertig
Journal:  Hosp Pharm       Date:  2021-08-05

Review 2.  Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?

Authors:  Pawan K Agrawal; Chandan Agrawal; Gerald Blunden
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

3.  Zhibaidihuang Decoction Ameliorates Cell Oxidative Stress by Regulating the Keap1-Nrf2-ARE Signalling Pathway.

Authors:  Pingping Wu; Bin Ding; Li Ye; Yanfen Huang; Jinjun Ji; Yongsheng Fan; Li Xu
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-12       Impact factor: 2.629

4.  Transcriptional characterization and response to defense elicitors of mevalonate pathway genes in cotton (Gossypium arboreum L.).

Authors:  Zhiqiang Zhang; Wei Liu; Zongbin Ma; Wei Zhu; Lin Jia
Journal:  PeerJ       Date:  2019-11-20       Impact factor: 2.984

Review 5.  Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment.

Authors:  Takashi Watanabe
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

6.  c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer.

Authors:  Jingjing Yao; Min Huang; Qinghong Shen; Ming Ding; Shaofang Yu; Yajuan Guo; Yuefang Lin; Yaqiu Zheng; Wenbo Chen; Wenxin Yan; Zhongqiu Liu; Dawei Wang; Ming Hu; Linlin Lu
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.810

Review 7.  Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma.

Authors:  Eman M Ragab; Doaa M El Gamal; Tarek M Mohamed; Abeer A Khamis
Journal:  Eur J Med Res       Date:  2022-09-08       Impact factor: 4.981

8.  Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment.

Authors:  Leila Khoshravan; Mehdi Dadashpour; Mehrdad Hashemi; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

9.  Microbial Platform for Terpenoid Production: Escherichia coli and Yeast.

Authors:  Chonglong Wang; Mudanguli Liwei; Ji-Bin Park; Seong-Hee Jeong; Gongyuan Wei; Yujun Wang; Seon-Won Kim
Journal:  Front Microbiol       Date:  2018-10-12       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.